Mercer Global Advisors »

Elevation Oncology shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6k 10k 0.56
2024-06-30 $28k 11k 2.70

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Apple (AAPL)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Msci Intl Moment (IMTM)
Ishares Tr Shrt Nat Mun Etf (SUB)
NVIDIA Corporation (NVDA)

View all positions for Mercer Global Advisors

Top funds holding Elevation Oncology

Frazier Life Sciences Management
Tang Capital Management
Farallon Capital Management
BlackRock
BVF
Aisling Capital Management
Vanguard Group
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Sphera Funds Management
OrbiMed Advisors
Millennium Management
Ikarian Capital

View all funds holding Elevation Oncology